Genomic Testing Panels

Targeted sequencing panels designed for longitudinal patient monitoring and treatment response assessment. Enables detection of minimal residual disease and tracking of genomic changes over time to inform ongoing clinical management.

Clinically validated sequencing panels specifically designed for early-stage cancer detection through liquid biopsy analysis. Supports non-invasive screening and enables identification of disease at earlier stages to improve patient outcomes.

Comprehensive molecular diagnostic panels for human health applications using advanced qPCR technology. These multiplex assays enable simultaneous detection of multiple pathogens relevant to clinical diagnostics.

Comprehensive sequencing panels for cancer detection and monitoring combining tissue and liquid biopsy approaches. Enables precise identification of low-frequency variants and supports informed treatment decision-making in oncology clinical practice and research.

Comprehensive multi-analyte diagnostic test panels for screening and diagnosis of multiple disorders simultaneously, optimizing laboratory efficiency and clinical workflow.

Diagnostic panels for specific disease areas including Alzheimer's disease, chronic kidney disease, acute kidney injury, colorectal cancer, and pancreatic cancer. These tests provide comprehensive diagnostic solutions for major disease conditions.

Portfolio of eight distinct research assay panels with customizable configurations designed to run on most PCR platforms. Panels are engineered to identify low-abundance targets and support cost-effective molecular research.

Comprehensive kits for simultaneous detection of multiple tumor-associated markers using IHC, PCR, or FISH methodologies. These panels enable comprehensive tumor characterization and subtyping.

Collection of pre-configured next-generation sequencing panels available for immediate clinical use. Enables rapid deployment of validated genomic testing workflows for common applications in oncology, constitutional genetics, and precision medicine.

A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.

Molecular testing kit for detecting breast cancer-related genetic alterations, enabling risk stratification and clinical decision-making in oncology care.

Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.